Health
1,000 UK doctors condemn medical association’s push to lift puberty blocker ban for minors
From LifeSiteNews
1,000 senior doctors signed an open letter to the British Medical Association after it lobbied for the NHS to lift a ban on puberty blockers for children following the Cass Review, which found the drugs were harmful.
On August 1, the British Medical Association (BMA) – the United Kingdom’s doctors’ union – called on the government to lift the ban on puberty blockers for minors. Weirdly, the BMA also stated that in their view the implementation of NHS England’s Cass Review should be “paused” despite the fact that, as the BBC noted, the review “took four years to carry out and was widely welcomed by the medical establishment in the U.K.” The BMA called the Cass Review’s recommendations – based on “the largest and most comprehensive review” on the subject seen, looking at 237 papers from 18 countries – “unsubstantiated.”
A spokesperson for the Department of Health and Social Care responded to the BMA, firmly rejecting both the request and the claim, stating, “The Cass Review is a robust report backed by clinicians and firmly grounded in evidence. NHS England will be implementing Dr. Cass’s recommendations so that children and young people get the safe, holistic support they need. We do not support a delay to vital improvements from the NHS to gender services.” Even the leftist Guardian ran an editorial criticizing the BMA’s position, stating, “The BMA’s stance on puberty blockers defies the key principle of medicine: first, do no harm.”
READ: FDA official recommends approval of puberty blockers despite suicide risk for gender-confused youth
As it turns out, there are plenty of physicians who are very unhappy with the BMA’s move – and they are now making their voices heard. This week, 1,000 senior doctors from across the U.K. published an open letter addressed to Professor Philip Banfield, chairman of the BMA.
“We write as doctors to say, ‘not in my name,’” the letter reads. “We are extremely disappointed that the BMA council had passed a motion to conduct a ‘critique’ of the Cass Review and to lobby to oppose its recommendations. The passing of the motion was opaque and secretive. It does not reflect the views of the wider membership, whose opinion you did not seek. We understand that no information will be released on the voting figures and how council members voted. That is a failure of accountability to members and is simply not acceptable.”
The open letter further emphasizes that the Cass Review “is the most comprehensive review into healthcare for children with gender related distress ever conducted” and urged the BMA to “abandon its pointless exercise” of attacking and opposing the recommendations. “By lobbying against the best evidence we have, the BMA is going against the principles of evidence-based medicine and against ethical practice.”
Among the signatories to the letter are 23 former or current clinical leaders at royal colleges, as well as the heads and former heads of some royal colleges.
The British Medical Association is the only main medical organization to oppose the Cass Review; all others have backed it. For example, Professor Sir Stephen Powis, NHS national medical director, stated, “These plans set out in detail how we will establish a fundamentally different and safer model of care for children and young people. The work Dr. Cass has undertaken has been invaluable in helping us shape the new service offer, and we have already begun our transformation of these services by opening two new regional centres this year.” Banfield responded on behalf of the BMA council to say that the points made in the letter would be considered during their ongoing evaluation.
As Josephine Bartosch observed, “it is becoming increasingly clear that the BMA is dangerously out of step with the medical consensus. The Cass Review has sent ripples across the world, and from lawsuits in the U.S. to a change of tack across Europe – medics are increasingly acknowledging that what is a crisis in youth mental health cannot be cured by changing bodies.”
Health
All 12 Vaccinated vs. Unvaccinated Studies Found the Same Thing: Unvaccinated Children Are Far Healthier
I joined Del Bigtree in studio on The HighWire to discuss what the data now make unavoidable: the CDC’s 81-dose hyper-vaccination schedule is driving the modern epidemics of chronic disease and autism.
This was not a philosophical debate or a clash of opinions. We walked through irrefutable, peer-reviewed evidence showing that whenever vaccinated and unvaccinated children are compared directly, the unvaccinated group is far healthier—every single time.
Reanalyzing the Largest Vaccinated vs. Unvaccinated Birth-Cohort Study Ever Conducted
At the center of our discussion was our peer-reviewed reanalysis of the Henry Ford Health System vaccinated vs. unvaccinated birth-cohort study (Lamerato et al.)—the largest and most rigorous comparison of its kind ever conducted.
 |
 |
|
The original authors relied heavily on Cox proportional hazards models, a time-adjusted approach that can soften absolute disease burden. Even so, nearly all chronic disease outcomes were higher in vaccinated children.
Our reanalysis used direct proportional comparisons, stripping away the smoothing and revealing the full magnitude of the signal.
- All 22 chronic disease categories favored the unvaccinated cohort when proportional disease burden was examined
- Cancer incidence was 54% higher in vaccinated children (0.0102 vs. 0.0066)
- When autism-associated conditions were grouped appropriately—including autism, ADHD, developmental delay, learning disability, speech disorder, neurologic impairment, seizures, and related diagnoses—the vaccinated cohort showed a 549% higher odds of autism-spectrum–associated clinical outcomes
The findings are internally consistent, biologically coherent, and concordant with every prior vaccinated vs. unvaccinated study, all of which show drastically poorer health outcomes among vaccinated children
The 12 Vaccinated vs. Unvaccinated Studies Regulators Ignore
In the McCullough Foundation Autism Report, we compiled all 12 vaccinated vs. unvaccinated pediatric studies currently available. These studies span different populations, countries, study designs, and data sources.
 |
Every single one reports the same overall pattern. Across all 12 studies, unvaccinated children consistently exhibit substantially lower rates of chronic disease, including:
- Autism and other neurodevelopmental disorders
- ADHD, tics, learning and speech disorders
- Asthma, allergies, eczema, and autoimmune conditions
- Chronic ear infections, skin disorders, and gastrointestinal illness
This level of consistency across independent datasets is precisely what epidemiology looks for when assessing causality. It also explains why no federal agency has ever conducted—or endorsed—a fully vaccinated vs. fully unvaccinated safety study.
Flu Shot Failure
We also addressed the persistent failure of seasonal influenza vaccination.
A large Cleveland Clinic cohort study of 53,402 employees followed participants during the 2024–2025 respiratory viral season and found:
- 82.1% of employees were vaccinated against influenza
- Vaccinated individuals had a 27% higher adjusted risk of influenza compared with the unvaccinated state (HR 1.27; 95% CI 1.07–1.51; p = 0.007)
- This corresponded to a negative vaccine effectiveness of −26.9% (95% CI −55.0 to −6.6%), meaning vaccination was associated with increased—not reduced—risk of influenza
 |
When vaccination exposure increases, chronic disease, neurodevelopmental disorders, and inflammatory illness increase with it. When children are unvaccinated, they are measurably healthier across virtually every outcome that matters.
The science needed to confront the chronic disease and autism epidemics already exists. What remains is the willingness to acknowledge it.
Epidemiologist and Foundation Administrator, McCullough Foundation
Support our mission: mcculloughfnd.org
Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.
FOCAL POINTS (Courageous Discourse) is a reader-supported publication.
To receive new posts and support my work, consider becoming a free or paid subscriber.
Daily Caller
Ex-FDA Commissioners Against Higher Vaccine Standards Took $6 Million From COVID Vaccine Makers
From the Daily Caller News Foundation
By Emily Kopp
The FDA old guard criticized the new leadership in a Dec. 3 New England Journal of Medicine (NEJM) letter over a higher regulatory bar for vaccines, namely the expectation that most new vaccine approvals will require randomized clinical trials, arguing it could hamper the market.
“Insisting on long, expensive outcomes studies for every updated formulation would delay the arrival of better-matched vaccines when new outbreaks emerge or when additional groups of patients could benefit,” the former commissioners wrote. “Abandoning the existing methods won’t ‘elevate vaccine science’ … It will subject vaccines to a substantially higher and more subjective approval bar.”
But while the former commissioners disclosed their conflicts of interest to the medical journal — per standard practice in scientific publishing — reporters didn’t relay them to the broader public in reports in the Washington Post, STAT News and CNN.
The headlines about a bipartisan rebuke from former occupants of FDA’s highest office give the impression that the Trump administration is contravening established science, but closer inspection reveals a revolving door between pharmaceutical corporations and the agencies overseeing them.
Three of the signatories have received payments totaling $6 million from manufacturers or former manufacturers of COVID vaccines.
Scott Gottlieb has received $2.1 million in cash and stock from his position on the Pfizer board of directors, where he has advised on ethics and regulatory compliance since 2019, according to company filings to the Securities and Exchange Commission. Stephen Ostroff has received $752,310 from Pfizer in consulting fees since 2020, according to OpenPayments.
Mark McClellan has received $3.3 million from Johnson & Johnson as a member of the board of directors since 2013, SEC filings also show. McClellan also consults for the new pharmaceutical arm of the alternative investment management company Blackstone, which invested $750 million in Moderna in April 2025.
Gottlieb and McClellan did not respond to requests for comment. Ostroff could not be reached for comment.
FDA Center for Biologics Evaluation and Research Director Vinay Prasad outlined the higher standards and shared the results of an internal analysis validating 10 reports of children’s deaths following the COVID-19 vaccine in a Nov. 28 memo to staff. He called for introspection and reform at the agency.
The NEJM letter criticizes Prasad for cracking down on a practice called “immunobridging” that infers vaccine efficacy from laboratory tests rather than assessing it through real-world reductions in disease or death. The FDA under the Biden administration expanded COVID vaccines to children using this “immunobridging” technique, extrapolating vaccine efficacy from adults to children based on antibody levels.
Norman Sharpless — who in addition to previously serving as acting FDA commissioner also served as the head of the National Institutes of Health’s National Cancer Institute — consults for Tempus, a company that collaborates with COVID vaccine maker BioNTech. He has helped steer $70 million in investments in biotech through a venture capital firm he founded in November 2024. Sharpless also disclosed $26,180 in payments in 2024 from Chugai Pharmaceutical, a Japanese pharmaceutical company that markets mRNA technology among other drugs, on OpenPayments.
“I was grateful for the opportunity to serve as NCI Director and Acting FDA Commissioner in the first Trump Administration, and strongly support many of the things President Trump is trying to do in the current Administration,” Sharpless said in an email.
Margaret Hamburg, another former FDA commissioner and signatory of the NEJM letter, has since 2020 earned $2.8 million as a member of the board of Alnylam Pharmaceuticals, which markets RNA interference (RNAi) technology.
Hamburg did not respond to a message on LinkedIn.
Most signatories disclosed income from biotech companies testing experimental cancer treatments. These products could face tighter scrutiny under Prasad, a hematologist-oncologist long wary of rubberstamping pricey oncology drugs — which Prasad points out often cause some toxicity — without plausible evidence of an improvement in quality of life or survival.
The former FDA commissioners disclosed ties to Sermonix Pharmaceuticals Inc.; OncoNano Medicine; incyclix; Nucleus Radiopharma; and N-Power, a contractor that runs oncology clinical trials.
Andrew von Eschenbach, who like Sharpless formerly served both as FDA commissioner and the head of the National Cancer Institute, disclosed stock in HistoSonics, a company with investments from Bezos Expeditions and Thiel Bio seeking FDA approval for ultrasound technology targeted at tumors.
Some FDA commissioners who signed onto the letter opposing changes to vaccine approvals have ties to biotechnology investment firms, namely McClellan, who consults Arsenal Capital; Janet Woodcock, who consults RA Capital Management; and Robert Califf, who owns stock in Population Health Partners.
Califf did not respond to an email requesting comment. Woodcock did not respond to requests for comment sent to two medical research advocacy groups with Woodcock on the board. Eschenbach did not respond to a LinkedIn message.
The two signatories without pharmaceutical ties may find their judgement challenged by the FDA investigation into COVID-19 vaccine deaths, having either implemented or formally defended the Biden administration’s headlong expansion of vaccines and boosters to healthy adults and children.
David Kessler executed Biden’s vaccination policy as chief science officer at the Department of Health and Human Services, helping to secure deals for shots with Pfizer and Moderna.
Meanwhile Jane Henney chaired a National Academies of Sciences, Engineering, and Medicine report published in October 2025 that praised the performance of FDA and Centers for Disease Control and Prevention (CDC) vaccine surveillance during the pandemic — underwritten with CDC funding.
That assessment clashes with that of a Senate report, citing internal documents from FDA, finding that CDC never updated its vaccine surveillance tool “V-Safe” to include cardiac symptoms, despite naming myocarditis as a potential adverse event by October 2020, and that top officials in the Biden administration delayed warning pediatricians and other providers about the risk of myocarditis after their approval in some children in May 2021, months after Israeli health officials first detected it in February 2021. The Senate investigation named Woodcock, a signatory of the NEJM letter, as one of the FDA officials who slow-walked the warning.
Inflation Reduction Act, Green New Deal Causing America’s Energy Crisis
Terror in Australia: 12 killed after gunmen open fire on Hanukkah celebration
Canada’s sudden rediscovery of energy ambition has been greeted with a familiar charge: hypocrisy
Chinese Billionaire Tried To Build US-Born Baby Empire As Overseas Elites Turn To American Surrogates
Canadian gov’t considers sharing census data on gender-confused children
Paris Climate Deal Now Decade-Old Disaster
Major tax changes in 2026: Report
-
Business24 hours agoArgentina’s Milei delivers results free-market critics said wouldn’t work
-
Alberta2 days agoAlberta’s new diagnostic policy appears to meet standard for Canada Health Act compliance
-
Health2 days agoRFK Jr reversing Biden-era policies on gender transition care for minors
-
Business1 day agoGeopolitics no longer drives oil prices the way it used to
-
Business23 hours agoDeadlocked Jury Zeroes In on Alleged US$40 Million PPE Fraud in Linda Sun PRC Influence Case
-
Censorship Industrial Complex1 day agoCanadian university censors free speech advocate who spoke out against Indigenous ‘mass grave’ hoax
-
Daily Caller1 day ago
Ex-FDA Commissioners Against Higher Vaccine Standards Took $6 Million From COVID Vaccine Makers
-
COVID-191 day agoFreedom Convoy protester appeals after judge dismissed challenge to frozen bank accounts